Search+Investment IdeasBrokerages have shared mixed views on select stocks. SynopsisIGI: Morgan Stanley stays bullish, citing strong certification-market growth and the company’s shift toward a consumer-focused business.Jindal Stainless: Goldman Sachs remains positive, backed by resilient earnings, improving profitability and continued debt reduction.Brokerages have shared mixed views on select stocks, with Morgan Stanley remaining bullish on International Gemological Institute (IGI), Goldman Sachs reiterating its positive stance on Jindal Stainless, and Citi maintaining a cautious outlook on Biocon.While IGI's long-term growth prospects are supported by a robust certification market and its transition towards a stronger consumer-focused business, Goldman Sachs believes Jindal Stainless is BYETMarkets.com 5 mins readAug 04, 2026, 10:12:00 AM ISTGift this Story to your friendsFONT SIZEAbcSmallAbcMediumAbcLargeSAVEPRINTCOMMENTContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories & personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions & in-depth stock reportsSubscribe NowETUh-oh! This is an exclusive story available for selected readers only.Worry not. You’re just a step away.What’s Included withETPrime Membership
Buy, Sell or Hold: Goldman Sachs maintains buy rating on Jindal Stainless; Citi recommends sell call on Biocon
IGI: Morgan Stanley stays bullish, citing strong certification-market growth and the company’s shift toward a consumer-focused business.Jindal Stainless: Goldman Sachs remains positive, backed by resilient earnings, improving profitability and continued debt reduction.
Goldman Sachs maintains buy on Jindal Stainless (earnings resilience, debt reduction); Citi recommends sell on Biocon. Divergent broker calls on Indian commodity stocks signal rupee volatility and macro cycles independent from enterprise tech capex decisions.






